AHL
FOLD

Abel Hall LLC’s Amicus Therapeutics FOLD Stock Holding History

Abel Hall LLC’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-19,286
Closed -$279K – 1006
2026
Q1 		$279K Buy
+19,286
New +$276K 0.06% 447

Other funds holding FOLD

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Abel Hall LLC's FOLD Position: Q2 2026 in Review

Abel Hall LLC sold out of Amicus Therapeutics (FOLD) in Q2 2026, closing a stake of 19,286 shares — an estimated $279K sold.

Abel Hall LLC first reported a position in FOLD in Q1 2026 and held it in 1 quarter. The position peaked at $279K in Q1 2026. 2 funds tracked by Wall St. Rank hold FOLD as of Q2 2026.

  • Abel Hall LLC reported no remaining Amicus Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Abel Hall LLC sold 19,286 Amicus Therapeutics shares in Q2 2026, an estimated $279K.
  • Abel Hall LLC first reported a position in Amicus Therapeutics in Q1 2026 and held it in 1 quarter.
  • Abel Hall LLC's Amicus Therapeutics position peaked at $279K in Q1 2026.
  • 2 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2026.

Based on Abel Hall LLC's 13F filing for Q2 2026, filed 24 Jul 2026.